← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Protein Potential, Llc
Rockville, MD
$14,675,112
Total funding
12
Grants
Funding over time
peak $3.2M · FY2005–17$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$14,675,112 · 12
By mechanism
R43$6,057,595 · 10
R01$5,754,468 · 1
R44$2,863,049 · 1
Investigators at Protein Potential, Llc
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Not enough data
Largest grants
Development of Enabling Vector/Antigen Expression Technology for an Orally-Delive$1,411,961
R01 · FY2012 · AI
Development of Enabling Vector/Antigen Expression Technology for an Orally-Delive$1,100,257
R01 · FY2014 · AI
Development of Enabling Vector/Antigen Expression Technology for an Orally-Delive$1,096,039
R01 · FY2016 · AI
Development of Enabling Vector/Antigen Expression Technology for an Orally-Delive$1,083,123
R01 · FY2015 · AI
Development of Enabling Vector/Antigen Expression Technology for an Orally-Delive$1,063,088
R01 · FY2013 · AI
Plasmodium vivax recombinant CS protein vaccine for malaria$1,000,000
R44 · FY2011 · AI
Plasmodium vivax recombinant CS protein vaccine for malaria$1,000,000
R44 · FY2010 · AI
Plasmodium vivax recombinant CS protein vaccine for malaria$863,049
R44 · FY2012 · AI
A SARS-CoV Spike Protein Vaccine$362,894
R43 · FY2005 · AI
Live Attenuated Oral Typhoid-Shigellosis Vaccine$307,387
R43 · FY2015 · AI
A SARS-CoV Spike Protein Vaccine$306,908
R43 · FY2004 · AI
Live Attenuated Oral Typhoid-Shigellosis Vaccine$301,810
R43 · FY2016 · AI
Immunizing Against Malaria by Inducing Both Protective Antibodies and CD8 T Cells$300,000
R43 · FY2012 · AI
Multi-ligand merozoite invasion blocking malaria vaccine$300,000
R43 · FY2012 · AI
Multi-stage multi-antigen Vaccine for interrupting Malaria Transmission$300,000
R43 · FY2012 · AI
Multi-ligand merozoite invasion blocking malaria vaccine$300,000
R43 · FY2013 · AI
Immunizing Against Malaria by Inducing Both Protective Antibodies and CD8 T Cells$300,000
R43 · FY2013 · AI
Multi-stage multi-antigen Vaccine for interrupting Malaria Transmission$300,000
R43 · FY2013 · AI
Recombinant Plasodium falciparum CelTOS vaccine$299,998
R43 · FY2008 · AI
Live Attenuated Oral Anthrax Vaccine$299,997
R43 · FY2010 · AI